Oxidative Stress Assay Global Market Report 2025

The oxidative stress assay market size has grown rapidly in recent years. It will grow from $0.96 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth during the historic period can be attributed to the increasing prevalence of chronic diseases, rising awareness of oxidative stress in aging, growing research in drug discovery and development, advancements in biotechnology and diagnostics, and the expanding demand for personalized medicine.

The oxidative stress assay market size is expected to see rapid growth in the next few years. It will grow to $1.53 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth during the forecast period can be driven by a greater focus on preventive healthcare, a growing geriatric population, advancements in biomarker discovery, increased research funding for oxidative stress-related diseases, and the rising adoption of personalized treatment approaches. Key trends in this period include advancements in high-throughput screening technologies, the integration of artificial intelligence for data analysis, the development of portable and point-of-care diagnostic devices, the increasing use of microfluidic devices for assays, and enhancements in the sensitivity and specificity of assay kits.

The increasing prevalence of chronic diseases is expected to drive the growth of the oxidative stress assay market. Chronic diseases, which are long-term conditions requiring ongoing medical management, have been rising due to factors such as lifestyle changes, aging populations, and environmental influences. Oxidative stress assays play a crucial role in detecting cellular damage linked to chronic diseases and monitoring the effectiveness of treatments that target oxidative stress. For example, in June 2023, Kidney Research UK reported that approximately 7.2 million people in the UK are living with chronic kidney disease (CKD), accounting for over 10% of the population. Of these, 3.25 million individuals are in the advanced stages, while 3.9 million are in the early stages. By 2033, the number of people affected by CKD is projected to rise to 7.61 million. This increasing incidence of chronic kidney disorders is contributing to the growth of the oxidative stress assay market.

Companies in the oxidative stress assay market are focusing on developing advanced measurement technologies to enhance diagnostic capabilities. These technologies assess the balance between free radicals and antioxidants in the body, helping to evaluate cellular damage and potential health risks. For instance, in October 2024, Memphasys, an Australia-based reproductive biotechnology company, introduced the RoXsta system, an innovative tool for measuring oxidative stress. The RoXsta system delivers rapid and accurate results in just six minutes, making it suitable for real-time clinical use. Its versatility enables testing across various biological fluids and food extracts, while its user-friendly design supports potential point-of-care applications.

In August 2023, Danaher Corporation, a US-based medical equipment company, acquired Abcam for $5.7 billion. This acquisition was aimed at expanding Danaher’s capabilities in the life sciences sector by integrating Abcam’s extensive portfolio of protein consumables, including antibodies, reagents, and assays that are essential for research and diagnostics. Abcam, a UK-based biotechnology company, specializes in developing assays and kits for measuring oxidative stress, further strengthening Danaher's presence in the growing market.

Major players in the oxidative stress assay market are Merck KGaA, Thermo Fisher Scientific, Danaher Corportaion, Labcorp Holdings Inc., Promega Corporation, Eagle Biosciences, Genova Diagnostics, Cayman Chemical, Enzo Biochem Inc., RayBiotech Inc., R&D Systems Inc., Santa Cruz Biotechnology Inc., Abnova Corporation, MyBioSource.com, CliniSciences Group, Hycult Biotech, ImmunoChemistry Technologies, Cell Biolabs, G-Biosciences, Cambridge Biosciences, and Reddot Biotech.

North America was the largest region in the oxidative stress assay market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in oxidative stress assay report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the oxidative stress assay market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

An oxidative stress assay is a laboratory test designed to measure oxidative stress levels within a biological system. It detects reactive oxygen species (ROS) or evaluates the antioxidant defense system's ability to neutralize oxidative damage. These assays are crucial for studying oxidative stress in various diseases, including neurodegenerative disorders, cardiovascular diseases, and cancer. By assessing oxidative damage markers, they provide insights into cellular health and oxidative imbalance.

The key products in the oxidative stress assay market include consumables and instruments. Consumables are materials that are used up during testing and require regular replacement. The assay types include cell-based assays, acellular assays, and animal models. Technologies used in these assays include spectrophotometry-based, fluorescence-based, chemiluminescence-based, and electrochemical assays. Applications span drug discovery and development, nutraceutical and food analysis, cosmetics and personal care products, and environmental monitoring. The primary end users include pharmaceutical and biotech companies, academic research institutes, clinical laboratories, contract research organizations, and others.

The oxidative stress assay market research report is one of a series of new reports that provides oxidative stress assay market statistics, including oxidative stress assay industry global market size, regional shares, competitors with a oxidative stress assay market share, detailed oxidative stress assay market segments, market trends and opportunities, and any further data you may need to thrive in the oxidative stress assay industry. This oxidative stress assay market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oxidative stress assay includes revenues earned by entities by providing services such as consultation services, diagnostic testing, and analysis for researchers and healthcare institutions to assess oxidative stress levels in biological samples. The market value includes the value of related goods sold by the service provider or included within the service offering. The oxidative stress assay market also includes sales of ROS detection kits, glutathione (GSH) assay kits, catalase activity assay kits, and mitochondrial ROS assay kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.